Gene Therapy / Diabetes Mellitus and Complications / Diabetes Mellitus and Its Complications / Diabetes mellitus / Stem Cell Therapy and Genetic Diagnostics / Diabetes mellitus, wound healing process / Liposomes to Cancer Cells, Gene Therapy to Cancer Cells, Glucocorticoid Receptor / Non-Vrial Gene Therapy and Nanotechnology / Stem Cells and Gene Therapy / Sistema Clasificador de Diabetes Mellitus Tipo 2 / Nanomedicnes and gene therapy / Diabetes Mellitus Type I / Type 2 Diabetes Mellitus / TCF7L2 Polymorphism In Type 2 Diabetes Mellitus / Type 2 Diabetes Mellitus and Lifestyles / Diabetes mellitus, wound healing process / Liposomes to Cancer Cells, Gene Therapy to Cancer Cells, Glucocorticoid Receptor / Non-Vrial Gene Therapy and Nanotechnology / Stem Cells and Gene Therapy / Sistema Clasificador de Diabetes Mellitus Tipo 2 / Nanomedicnes and gene therapy / Diabetes Mellitus Type I / Type 2 Diabetes Mellitus / TCF7L2 Polymorphism In Type 2 Diabetes Mellitus / Type 2 Diabetes Mellitus and Lifestyles
Diabetes / Quality of life / Spain / Heart Failure / Humans / Heart / Randomized Trial / Group Intervention / Disease Management / Type 2 Diabetes Mellitus / Continuity of Patient Care / Diabetes Care / Ambulatory Care / Control Group / Heart / Randomized Trial / Group Intervention / Disease Management / Type 2 Diabetes Mellitus / Continuity of Patient Care / Diabetes Care / Ambulatory Care / Control Group
China / Public Health / Humans / Female / Male / Aged / Middle Aged / Health Expenditures / Adult / Public health systems and services research / Cost Benefit Analysis / Health surveys / Health Care Costs / Type 2 Diabetes Mellitus / Cross Sectional Studies / The American / Aged / Middle Aged / Health Expenditures / Adult / Public health systems and services research / Cost Benefit Analysis / Health surveys / Health Care Costs / Type 2 Diabetes Mellitus / Cross Sectional Studies / The American